Do you want to read an article? Please log in or register.
The Effect of 6 Months' Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings
Glycemic Control
Related content
COMMENTED
Further Publications
Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
Front Endocrinol (Lausanne).
Fleseriu M, Iweha C, Salgado L, Mazzuco TL, Campigotto F, Maamari R, Limumpornpetch P
doi: 10.3389/fendo.2019.00436.
Diabetes - GeneralType 2 Diabetes
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1RA and DPP4 Therapies in Patients With Type 2 Diabetes
Diabetes Care.
Carls GS, Tuttle E, Tan RD, Huynh J, Yee J, Edelman SV, Polonsky WH
doi: 10.2337/dc16-2725.
Diabetes - GeneralType 1 DiabetesGlycemic Control
The Effects of Continuous Glucose Monitoring System on Patient Outcomes and Associated Costs in a Real-World Setting
Diabet Med
Triki N, Yekutiel N, Levi L, Azuri J
doi: 10.1111/dme.14518
Lipids
Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors
Am J Cardiovasc Drugs.
Rane PB, Patel J, Harrison DJ, Shepherd J, Leith A, Bailey H, Piercy J
doi: 10.1007/s40256-017-0246-z.
Diabetes - GeneralType 2 Diabetes
Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: real-world data from a diabetes out-patient clinic
Diabet Med
Hansen KB, Svendstrup M, Lund A, Knop FK, Vilsbøll T, Vestergaard H
doi: 10.1111/dme.14655
COMMENTED
Type 1 Diabetes
Glucose control using fast-acting insulin aspart in a real-world setting: a 1-year two-center study in people with type 1 diabetes using continuous glucose monitoring
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Billion L, Charleer S, Verbraeken L, Sterckx M, Vangelabbeek K, De Block N, Janssen C, Van Dessel K, Dirinck E, Peiffer F, Bolsens N, Mathieu C, Gillard P, De Block C
doi: 10.1111/dom.14527
COMMENTED
Diabetes - GeneralType 2 Diabetes
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes
Diabetes Care.
Carls GS, Tuttle E, Tan RD, Huynh J, Yee J, Edelman SV, Polonsky WH
doi: 10.2337/dc16-2725.
Type 2 Diabetes
Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg Study
Ann Med.
Pérez-Belmonte LM, Osuna-Sánchez J, Millán-Gómez M, López-Carmona MD, Gómez-Doblas JJ, Cobos-Palacios L, Sanz-Cánovas J, Barbancho MA, Lara JP, Jiménez-Navarro M, Bernal-López MR, Gómez-Huelgas R
doi: 10.1080/07853890.
COMMENTED
Type 2 DiabetesGlycemic Control
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial
Lancet Diabetes Endocrinol.
D'Aiuto F, Gkranias N, Bhowruth D, Khan T, Orlandi M, Suvan J, Masi S, Tsakos G, Hurel S, Hingorani AD, Donos N, Deanfield JE; TASTE Group
doi: 10.1016/S2213-